Literature DB >> 24360737

Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.

Dong Fang1, Geng-Yan Xiong1, Xue-Song Li2, Xiao-Peng Chen1, Lei Zhang1, Lin Yao1, Zhi-Song He1, Li-Qun Zhou3.   

Abstract

BACKGROUND/
PURPOSE: There is currently no consensus about the pattern and risk factors of bladder recurrence after nephroureterectomy, especially in the Chinese population. We evaluated the pattern and risk factors based on data from a large Chinese center.
METHODS: The clinical and pathological data of 438 patients with upper tract urothelial carcinoma (UTUC), who underwent nephroureterectomy at Peking University First Hospital, Beijing, China between 2000 and 2010, was retrospectively analyzed. Univariate analysis by log-rank test and multivariate analysis by Cox proportional hazards regression model were used to determine the independent risk factors.
RESULTS: A total of 135 patients (30.8%) developed intravesical recurrence within a median follow-up of 45 months (range: 12-144 months). The median interval of bladder recurrence was 15 months (range: 2.0-98.0 months), and the two peaks for recurrence were 4-6 months and 17-19 months. Lower tumor grade, tumor multifocality, concomitant carcinoma in situ (CIS) and tumors located in the lower ureter were significant risk factors by univariate and multivariate analysis. A risk-scoring system was developed and a significant difference was found between different risk evaluations. Patients with concomitant CIS tended to develop a late bladder recurrence. One hundred and eighteen patients (87.4%) received transurethral resection after bladder tumor recurrence.
CONCLUSION: Lower tumor grade, tumor multifocality, concomitant CIS and tumors located in the lower ureter tend to be predictive for bladder recurrence after nephroureterectomy, although the underlying mechanism is not fully elucidated, and the scoring system could help risk stratification. Most recurrent tumors could be treated by transurethral resection and there were two peaks for recurrence, which is probably related to the mechanisms and may be unique to the Chinese population.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  bladder tumor; nephroureterectomy; recurrence; risk factors; upper tract urothelial carcinoma (UTUC)

Mesh:

Year:  2013        PMID: 24360737     DOI: 10.1016/j.jfma.2013.11.004

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  14 in total

1.  Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.

Authors:  Go Kobayashi; Tetsutaro Hayashi; Kazuhiro Sentani; Takashi Babasaki; Yohei Sekino; Shogo Inoue; Naohiro Uraoka; Masanori Hanamoto; Hiroyuki Nose; Jun Teishima; Naohide Oue; Akio Matsubara; Naomi Sasaki; Wataru Yasui
Journal:  Virchows Arch       Date:  2021-11-29       Impact factor: 4.535

2.  Prevalence, clinicopathological features, and prognosis in upper tract urinary carcinoma patients with severe preoperative chronic kidney disease.

Authors:  Zhengqing Bao; Yicong Du; Yiming Yuan; Yuze Zhu; Cheng Qian; Yonghao Zhan; Dong Fang; Gengyan Xiong; Lei Zhang; Xuesong Li; Liqun Zhou
Journal:  Transl Androl Urol       Date:  2019-12

3.  Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.

Authors:  Yang Hyun Cho; Young Ho Seo; Seung Jun Chung; Insang Hwang; Ho Song Yu; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Jun Eul Hwang; Suk Hee Heo; Geun Soo Kim; Eu Chang Hwang
Journal:  Korean J Urol       Date:  2014-07-11

4.  Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.

Authors:  Song Wu; Zhao Yang; Rui Ye; Dan An; Chong Li; Yitian Wang; Yongqiang Wang; Yi Huang; Huan Liu; Feida Li; Luyun He; Da Sun; Yuan Yu; Qiaoling Li; Peide Huang; Meng Zhang; Xin Zhao; Tengteng Bi; Xuehan Zhuang; Liyan Zhang; Jingxiao Lu; Xiaojuan Sun; Fangjian Zhou; Chunxiao Liu; Guosheng Yang; Yong Hou; Zusen Fan; Zhiming Cai
Journal:  Oncotarget       Date:  2016-01-19

5.  The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.

Authors:  Xiaohong Su; Dong Fang; Xuesong Li; Gengyan Xiong; Lei Zhang; Han Hao; Yanqing Gong; Zheng Zhang; Liqun Zhou
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

Review 6.  Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.

Authors:  Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-01-31

7.  High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Authors:  Bentao Shi; Boxing Su; Dong Fang; Yuan Tang; Gengyan Xiong; Zhongqiang Guo; Qun He; Xinyu Yang; Wei Zhao; Yinglu Guo; Xuesong Li; Liqun Zhou
Journal:  BMC Cancer       Date:  2015-05-09       Impact factor: 4.430

8.  Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy.

Authors:  Pei Liu; Xiao-Hong Su; Geng-Yan Xiong; Xue-Song Li; Li-Qun Zhou
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

9.  Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma.

Authors:  Dong Fang; Shiming He; Gengyan Xiong; Nirmish Singla; Zhenpeng Cao; Lei Zhang; Xuesong Li; Liqun Zhou
Journal:  BMC Urol       Date:  2018-03-27       Impact factor: 2.264

10.  Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study.

Authors:  Chuan-Shu Chen; Jian-Ri Li; Shian-Shiang Wang; Cheng-Kuang Yang; Chen-Li Cheng; Chi-Rei Yang; Yen-Chuan Ou; Hao-Chung Ho; Chia-Yen Lin; Sheng-Chun Hung; Cheng-Che Chen; Shu-Chi Wang; Kun-Yuan Chiu; Shun-Fa Yang
Journal:  Diagnostics (Basel)       Date:  2020-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.